Home > Insider Trading > Filing (0001144204-15-071682)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1293310	Kalobios Pharmaceuticals Inc	KBIO	Pharmaceutical Preparations (2834)	770557236

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1658857	Marek Biestek	108-20 71St Ave Apt Ph2C Forest Hills NY 11375		Yes	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-12-16	10,000	$29.32	250,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

On December 16, 2015, in connection with a private placement of the Issuer's securities that was announced and priced on December 3, 2015, Marek Biestek acquired 10,000 shares of the Issuer's common stock, par value $0.001 per share, at a purchase price of $29.32 per share (which was the announced price for the private placement). The aggregate purchase price paid by Marek Biestek in the transaction was $293,200.
The securities reported herein are owned directly by Marek Biestek, who is a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934. Marek Biestek individually owns less than 10%. There is no voting or ownership agreement amongst the group members and the other members of the group do not have a pecuniary interest in the shares reported herein. Correspondingly, Mr. Biestek does not have a pecuniary interest in the shares owned by the other members of the group.